Ablation of Consecutive Atrial Tachycardia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEvangelical Hospital Düsseldorf
About this trial
Ablation of consecutive atrial tachycardia (AT) after ablation of atrial fibrillation (AF) or cardiac surgery can be challenging due to complex substrate and AT mechanisms. A substantial portion of patients is known to show various tachycardias and recurrences occur in a noticeable number of cases. With the availability of novel ultra-high-density mapping techniques characterization and understanding of AT mechanisms and underlying substrate can be improved. Aim of this prospective, multi-center, randomized study is to compare a standard AT ablation approach versus minimalized ablation of the clinical AT in regards to arrhythmia free survival.
Eligibility criteria
Qualifiers
Consecutive AT subsequent to prior AF ablation procedure or cardiac surgery
Surface ECG-documentation of AT as primary clinical arrhythmia
ECG indicating stable, map-able AT (stable activation sequence, and CL stability) with cycle length ≥ 200ms
Disqualifiers
< 18 years
No previous atrial fibrillation ablation procedure or cardiac surgery
Pregnant women or women of childbearing potential without a negative pregnancy test within 48 hours prior to treatment
History of hemorrhagic diathesis or other coagulopathies
Trial design
Treatments tested in this trial
- Catheter ablation
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov